The addition of Zytiga (abiraterone) to Truqap (capivasertib) significantly prolonged radiographic progression-free survival ...

However, men with higher PSA levels did show modest improvements in survival, suggesting that hormone therapy might be worthwhile for them. PSA (prostate-specific antigen) is produced by the prostate ...

The methods of diagnosing and treating localised prostate cancer has changed significantly in the last two decades.

A central aim of prostate cancer treatment is to prolong survival, but trials often overlook another key goal: Improving — or at least maintaining — quality of life (QoL). The recent American Society ...

Treatment choice for localized prostate cancer depends on cancer aggressiveness and quality-of-life factors, such as sexual functioning. Active surveillance is a safe option for appropriate patients, ...